The Role of Emerging Therapies for Retinal Disease in Clinical Practice
Host: Rishi P. Singh, MD
\n\n Host: Mark R. Barakat, MD
\n\n Host: Arshad M. Khanani, MD, MA
\n\n Host: Christina Y. Weng, MD, MBA
\n\n\n \n
This program will focus on the clinical trial and real-world data about the novel and emerging therapies for the treatment of dry age-related macular degeneration, wet age-related macular degeneration, diabetic retinopathy, and diabetic macular edema and how these therapies may be integrated into real-world clinical practice.